ATE288272T1 - Quetiapin granulat - Google Patents

Quetiapin granulat

Info

Publication number
ATE288272T1
ATE288272T1 AT00960855T AT00960855T ATE288272T1 AT E288272 T1 ATE288272 T1 AT E288272T1 AT 00960855 T AT00960855 T AT 00960855T AT 00960855 T AT00960855 T AT 00960855T AT E288272 T1 ATE288272 T1 AT E288272T1
Authority
AT
Austria
Prior art keywords
quetiapine granules
quetiapine
granules
Prior art date
Application number
AT00960855T
Other languages
English (en)
Inventor
Daniel Boyd Brown
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10861288&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE288272(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE288272T1 publication Critical patent/ATE288272T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
AT00960855T 1999-09-21 2000-09-18 Quetiapin granulat ATE288272T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9922271.3A GB9922271D0 (en) 1999-09-21 1999-09-21 Formulation
PCT/GB2000/003598 WO2001021179A1 (en) 1999-09-21 2000-09-18 Quetiapine granules

Publications (1)

Publication Number Publication Date
ATE288272T1 true ATE288272T1 (de) 2005-02-15

Family

ID=10861288

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00960855T ATE288272T1 (de) 1999-09-21 2000-09-18 Quetiapin granulat

Country Status (37)

Country Link
US (3) US6599897B1 (de)
EP (1) EP1218009B1 (de)
JP (1) JP2003509461A (de)
KR (1) KR100748823B1 (de)
CN (3) CN1331472C (de)
AR (1) AR032596A1 (de)
AT (1) ATE288272T1 (de)
AU (1) AU776292B2 (de)
BG (1) BG65469B1 (de)
BR (1) BR0014107A (de)
CA (1) CA2383131A1 (de)
CO (1) CO5180585A1 (de)
CZ (1) CZ301585B6 (de)
DE (1) DE60017923T2 (de)
DK (1) DK1218009T3 (de)
EE (1) EE200200150A (de)
EG (1) EG24226A (de)
ES (1) ES2235941T3 (de)
GB (2) GB9922271D0 (de)
HK (1) HK1047706B (de)
HU (1) HUP0203531A3 (de)
IL (2) IL148440A0 (de)
IS (1) IS2139B (de)
MX (1) MXPA02002627A (de)
MY (1) MY130208A (de)
NO (1) NO320908B1 (de)
NZ (1) NZ517549A (de)
PL (1) PL198824B1 (de)
PT (1) PT1218009E (de)
RU (1) RU2256453C2 (de)
SI (1) SI1218009T1 (de)
SK (1) SK286884B6 (de)
TR (1) TR200200716T2 (de)
TW (1) TWI226832B (de)
UA (1) UA73529C2 (de)
WO (1) WO2001021179A1 (de)
ZA (1) ZA200201709B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9922271D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Formulation
SE0102855D0 (sv) * 2001-08-27 2001-08-27 Astrazeneca Ab Method of treatment
WO2003039516A1 (en) * 2001-11-07 2003-05-15 Fujisawa Pharmaceuticla Co., Ltd. Method for improving dissolution of poorly dispersible medicaments
JP4514473B2 (ja) * 2004-02-23 2010-07-28 富士通株式会社 コンピュータシステム、中央装置及びプログラム実行方法
UA88792C2 (ru) * 2004-11-10 2009-11-25 Таргасепт, Інк. Гидроксибензоатные соли метаникотиновых соединений
US7459469B2 (en) 2004-11-10 2008-12-02 Targacept, Inc. Hydroxybenzoate salts of metanicotine compounds
WO2006117700A2 (en) * 2005-04-21 2006-11-09 Medichem, S.A. Process for preparing quetiapine and quetiapine fumarate
EP1976487A2 (de) 2006-01-25 2008-10-08 Astron Research Limited Dosierung mit verzögerter freigabe von phenothiazin-derivaten mit kanalisierern
TWI389889B (zh) * 2006-05-09 2013-03-21 Targacept Inc （２ｓ）-（４ｅ）-ｎ-甲基-５-〔３-（５-異丙氧基吡啶）基〕-４-戊烯-２-胺之新穎多晶型
EP2133338A1 (de) * 2006-05-09 2009-12-16 AstraZeneca AB Salzformen von (2S)-(4E)-N-Methyl-5-[(5-Isopropoxy)pyridin-3-yl]-4-Penten-2-Amin
CA2657202A1 (en) * 2006-07-28 2008-01-31 Farmaprojects, S.A. Extended release pharmaceutical formulation of metoprolol and process for its preparation
AR062860A1 (es) * 2006-09-15 2008-12-10 Astrazeneca Ab Combinaciones terapeuticas 482
WO2008052354A1 (en) * 2006-11-03 2008-05-08 University Of Saskatchewan Method of treating demyelination diseases
US20100028447A1 (en) * 2007-01-22 2010-02-04 Targacept, Inc. Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs
ATE480227T1 (de) * 2007-02-14 2010-09-15 Lesvi Laboratorios Sl Pharmazeutische zusammensetzungen mit quetiapinfumarat
JP2011512818A (ja) * 2008-02-27 2011-04-28 キャドバリー アダムス ユーエスエー エルエルシー 複数領域菓子
EA018638B1 (ru) 2008-08-01 2013-09-30 Крка, Товарна Здравил, Д. Д., Ново Место Композиция кветиапина
DE102008046650A1 (de) 2008-09-10 2010-03-11 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Quetiapin enthaltende Retardtablette
US8715699B2 (en) 2009-12-31 2014-05-06 Kempharm, Inc. Amino acid conjugates of quetiapine, process for making and using the same
EP2544536B1 (de) 2010-03-11 2018-12-12 Kempharm, Inc. Fettsäurekonjugate aus quetiapin sowie verfahren zu ihrer herstellung und verwendung
KR20130081221A (ko) 2010-05-20 2013-07-16 아스트라제네카 아베 아릴 치환된 올레핀계 아민의 신규 제조 방법
DE102010033527A1 (de) 2010-08-05 2012-02-09 Acino Pharma Ag Quetiapin-Tabletten
DE102011115690A1 (de) 2011-10-11 2013-04-11 Acino Pharma Ag Quetiapin enthaltende Formulierungen
US9993486B1 (en) 2017-06-19 2018-06-12 Tlc Therapeutics, Llc Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailability

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
GB8705574D0 (en) * 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound
ATE86111T1 (de) * 1989-08-31 1993-03-15 Takeda Chemical Industries Ltd Vitamin-b12-zusammensetzung.
IT1250701B (it) * 1991-07-24 1995-04-21 Angelini Francesco Ist Ricerca Composizione farmaceutica solida per uso orale a base di dapiprazolo
JPH06100602A (ja) * 1992-09-18 1994-04-12 Asahi Chem Ind Co Ltd 経口固形製剤およびその製造方法
US5397576A (en) * 1992-09-23 1995-03-14 Hoffmann-La Roche Inc. Spray triturated micronutrient compositions
ZA973433B (en) * 1996-04-24 1997-12-10 Shionogi & Co A sertindole-containing preparation and a method for producing the same.
US5948437A (en) 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
BR9713215A (pt) * 1996-09-24 2000-04-04 Lilly Co Eli Formulação de partìcula revestida
US7919119B2 (en) * 1999-05-27 2011-04-05 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
GB9922271D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Formulation

Also Published As

Publication number Publication date
NO320908B1 (no) 2006-02-13
GB9922271D0 (en) 1999-11-17
EE200200150A (et) 2003-04-15
ZA200201709B (en) 2003-05-28
CN1331472C (zh) 2007-08-15
PL357369A1 (en) 2004-07-26
US6599897B1 (en) 2003-07-29
NO20021394D0 (no) 2002-03-20
US20060159768A1 (en) 2006-07-20
CN1374867A (zh) 2002-10-16
KR20020033186A (ko) 2002-05-04
CN1188130C (zh) 2005-02-09
SK3722002A3 (en) 2002-07-02
CZ2002974A3 (cs) 2002-06-12
TR200200716T2 (tr) 2002-06-21
HUP0203531A2 (hu) 2003-02-28
AU7302300A (en) 2001-04-24
CN1626094A (zh) 2005-06-15
NZ517549A (en) 2003-10-31
HUP0203531A3 (en) 2004-12-28
IS2139B (is) 2006-08-15
AR032596A1 (es) 2003-11-19
MY130208A (en) 2007-06-29
CN1899288A (zh) 2007-01-24
IS6308A (is) 2002-03-19
IL148440A (en) 2007-07-04
SK286884B6 (sk) 2009-07-06
BG65469B1 (bg) 2008-09-30
RU2256453C2 (ru) 2005-07-20
GB0021406D0 (en) 2000-10-18
EG24226A (en) 2008-11-10
CO5180585A1 (es) 2002-07-30
HK1047706A1 (en) 2003-03-07
CZ301585B6 (cs) 2010-04-21
BR0014107A (pt) 2002-08-20
UA73529C2 (uk) 2005-08-15
US20040228914A1 (en) 2004-11-18
MXPA02002627A (es) 2002-07-30
ES2235941T3 (es) 2005-07-16
TWI226832B (en) 2005-01-21
IL148440A0 (en) 2002-09-12
JP2003509461A (ja) 2003-03-11
DK1218009T3 (da) 2005-05-09
DE60017923T2 (de) 2006-01-12
PL198824B1 (pl) 2008-07-31
DE60017923D1 (de) 2005-03-10
NO20021394L (no) 2002-03-20
BG106509A (en) 2002-12-29
EP1218009B1 (de) 2005-02-02
US7022692B2 (en) 2006-04-04
HK1047706B (zh) 2005-06-10
PT1218009E (pt) 2005-05-31
AU776292B2 (en) 2004-09-02
EP1218009A1 (de) 2002-07-03
CA2383131A1 (en) 2001-03-29
KR100748823B1 (ko) 2007-08-13
SI1218009T1 (en) 2005-06-30
WO2001021179A1 (en) 2001-03-29

Similar Documents

Publication Publication Date Title
ATE288272T1 (de) Quetiapin granulat
ID26447A (id) Turunan eritropoietin
DE50007846D1 (de) Dreschkorb
NO20015097L (no) Brönnpakning
NO20013858D0 (no) Valdecoxibpreparater
DE60021217D1 (de) Ostomievorrichtung
DK1150917T3 (da) Taphane
NO20020278L (no) Fosfattransportinhibitorer
NO20003750L (no) Anti-dreiemomentverktöy
ATA111299A (de) Schnullersauger
ID30214A (id) Turunan resorsinol
DE50008613D1 (de) Sicherungsring
FI19992631A (fi) Radiaalimäntähydraulimoottori
DE60020904D1 (de) Münzausgabevorrichtung
DE60034087D1 (de) Farbeditiersystem
DE50007090D1 (de) Autothermer reformierungsreaktor
NO20005774L (no) Leketöyanordning
ATA121799A (de) Ausbeulgerät
NO20006322L (no) Glibrett
PT1194411E (pt) Benzoilpiridazinas
DK199901559A (da) Stomi/brok-bandage
FR2800187B1 (fr) Souris-bagues
DE60013067D1 (de) Schussfadenaussgleichsbremse
ATA107599A (de) Heizwasserbereiter
NO20006641D0 (no) Innsettingsbössing

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1218009

Country of ref document: EP